Baxter in talks to buy Gambro for about $4 billion
Baxter International Inc is in talks to buy Swedish medical-equipment maker Gambro for about $4 billion, according to a source familiar with the situation.
Blood therapy products maker Baxter International Inc said it would buy the blood disorder-related assets of privately held biopharmaceutical firm Archemix for a $30 million upfront payment.